SEC Form EFFECT filed by Calliditas Therapeutics AB
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | September 16, 2024 |
Accession Number: | 0001104659-24-099792 | ||||||
Submission Type: | POS AM | ||||||
|